Bio-Techne (TECH) Share-based Compensation Growth (3y) (2012 - 2026)
Powered by 
Analysis
Bio-Techne (TECH) Share-based Compensation Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 12.91% |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 6.35% |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 17.49% |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 9.95% |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 4.55% |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 30.98% |
| 10 | Bio-Techne | 11.29 Bn | 11.03 Bn | 211.39 Mn | 65.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 65.20% |
| Mar 31, 2026 | 612.08% |
| Dec 31, 2025 | 3.85% |
| Sep 30, 2025 | -26.42% |
| Jun 30, 2025 | -28.83% |
| Mar 31, 2025 | 11.87% |
| Dec 31, 2024 | 11.79% |
| Sep 30, 2024 | -51.88% |
| Jun 30, 2024 | -15.96% |
| Mar 31, 2024 | -42.05% |
| Dec 31, 2023 | 47.48% |
| Sep 30, 2023 | -79.48% |
| Jun 30, 2023 | -31.30% |
| Mar 31, 2023 | 0.90% |
| Dec 31, 2022 | 43.79% |
| Sep 30, 2022 | -77.37% |
| Jun 30, 2022 | 15.80% |
| Mar 31, 2022 | -33.23% |
| Dec 31, 2021 | 51.36% |
| Sep 30, 2021 | 12.74% |